Pirfenidone Tablet
Product Images NDC 60505-4682

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Pirfenidone (NDC 60505-4682). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1.jpg (Figure1)

A cumulative distribution graph comparing the percentage of patients treated with Pirfenidone versus placebo, showing absolute change in %FVC from baseline to week 52. The x-axis represents change in %FVC, with worsening on the left and no decline on the right, while the y-axis shows the percentage of patients. The graph includes data lines for Pirfenidone (n=278) and placebo (n=277).*

FDA Label Image

Figure2.jpg (Figure2)

A line graph showing mean change in FVC (mL) over 52 weeks comparing Pirfenidone and placebo groups. The solid line with square markers represents Pirfenidone (n=278), and the dashed line with triangle markers represents placebo (n=277), illustrating greater decline in FVC in the placebo group over time.*

FDA Label Image

Figure3.jpg (Figure3)

Kaplan-Meier survival curve depicting percentage of patients alive over time in weeks for Pirfenidone (n=623) versus Placebo (n=624). The graph shows patient survival trends for up to 120 weeks, with a hazard ratio (HR) of 0.75 (95% CI: 0.51-1.11). The number of patients at risk is listed at specific time points below the x-axis.*

FDA Label Image

Lbl267mg90s.jpg (Lbl267mg90s)

Label for Pirfenidone Tablets 267 mg oral tablets by Apotex Corp. The package contains 90 tablets and includes storage instructions, dosage information referencing the package insert, and manufacturer details from Apotex Inc., Toronto, Ontario. The label features a barcode and clear text identifying the product strength and quantity.*

FDA Label Image

Lbl801mg90s.jpg (Lbl801mg90s)

Label for Pirfenidone Tablets 801 mg oral tablets by Apotex Corp. The label states packaging for 90 tablets and includes storage instructions and barcode. Manufactured by Apotex Inc., Toronto, Ontario, Canada, and Apotex Corp., Weston, Florida, USA.*

FDA Label Image

Structure.jpg (Structure)

Chemical structure of pirfenidone, showing a pyridone ring with a methyl group and a phenyl group attached.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.